Saksoft Q2 FY27: consolidated PAT down 11% YoY to ₹32.1 Cr as margins compress
PAT -10.7% YoY · revenue -3.82% · margins compressing
₹248.61 Cr
-3.82% YoY
₹32.12 Cr
-10.7% YoY
12.77%
-0.8pp YoY
₹2.49
Saksoft's consolidated PAT for Q2 FY27 was ₹32.12 Cr, down 10.7% year-on-year from ₹35.97 Cr, on revenue of ₹248.61 Cr that slipped 3.8% YoY (₹258.49 Cr) — a YoY decline in both lines, even though PAT rose 9.6% sequentially from Q1's ₹29.29 Cr and revenue was flat QoQ (₹248.62 Cr). Net margin fell to 12.77% of total income from 13.58% a year ago (though up from Q1's 11.70%), while operating margin (segment result/revenue) compressed to 17.60% from 19.58% YoY and from 18.26% in Q1 — the squeeze is on the operating line, not just tax or one-offs, since none exist this quarter. The margin pressure traces to the BFS and Commerce verticals: BFS segment profit fell 33.5% YoY to ₹10.88 Cr on a 7.7% revenue decline, and Commerce segment profit collapsed 61.2% YoY to ₹1.03 Cr on a 13.8% revenue drop. Emerging vertical, now the largest segment at ~46% of revenue, was the one bright spot — segment profit rose 10.4% YoY to ₹22.97 Cr even as its revenue dipped 4.5%, effectively absorbing the hit elsewhere. Logistics revenue grew 14.0% YoY to ₹39.54 Cr but segment profit still fell 17.7%, pointing to pricing or mix pressure within that vertical too.
Q2 FY-2027 vs prior quarters
No brokerage consensus for this specific quarter surfaced in search, so vsStreet is unknown; the house view after Q1 (MNCL, "broadly in-line, maintain buy") had flagged guidance as intact and expected H2 FY27 to carry the growth. Against management's own FY27 guidance of ₹1,200-1,250 Cr (19-24% growth on the ₹1,007 Cr FY26 base), H1 FY27 consolidated revenue of ₹497.23 Cr is actually down 2.0% YoY (₹507.57 Cr in H1 FY26) — tracking well off that pace. Hitting even the low end of guidance now needs H2 revenue of roughly ₹703 Cr, a 41% jump over the H1 run-rate (₹753 Cr, a 51% jump, for the top end), which looks increasingly stretched against this quarter's flat-to-down trend; management itself had flagged it would "restate guidance at end of Q2 if needed," so a formal revision is a live possibility. No separate press release accompanied this filing, so there is no management commentary to reconcile against the print. Corporate-action-wise, the Board declared an interim dividend of ₹0.50/share (record date November 10, 2026) alongside the results, and the NCLT-sanctioned Augmento Labs amalgamation (appointed date April 1, 2026) became effective this quarter, restating standalone — but not consolidated — financials; a new CEO was also named for the US subsidiary in late September. Standalone PAT was ₹22.82 Cr (EPS ₹1.72) against consolidated PAT of ₹32.12 Cr (EPS ₹2.49), with overseas subsidiaries contributing roughly 29% of the consolidated profit.
The stock went into the print at ₹135.31, down 4.7% over the past month of trading.
FY27 revenue guidance: ₹1,200-1,250 Cr (19-24% growth on ₹1,007 Cr FY26 base). Margin guidance: EBITDA 18%+ implied. Will restate end of Q2 if needed. No capex guidance.
— This quarter: missed
W1
Whether management formally revises the FY27 revenue guidance of ₹1,200-1,250 Cr given H1's ₹497.23 Cr run-rate (down 2.0% YoY) — company said it would restate 'at end of Q2 if needed'
W2
BFS and Commerce segment recovery: BFS segment profit -33.5% YoY to ₹10.88 Cr and Commerce -61.2% YoY to ₹1.03 Cr this quarter were the main drag on consolidated OPM (17.60% vs 19.58% a year ago)
W3
Emerging vertical's ability to keep offsetting weakness elsewhere — segment profit +10.4% YoY to ₹22.97 Cr on ~46% of group revenue this quarter
Clean scanned statement, both standalone and consolidated P&L fully legible; totalIncome and PBT-tax=PAT tie out exactly for both bases. No exceptional items in Q2 FY27 or the Q2 FY26 comparative (the ₹4.86 Cr consolidated / ₹4.03 Cr standalone labour-code exceptional item sits only in the FY26 annual column, booked in Q3 FY26), so no adjustment needed. Consolidated YoY comparatives are unaffected by the Augmento Labs merger — note 6 states the merger restated only standalone prior-period figures, with no impact on consolidated.
Flat Quarter, Guidance Under Strain, FY27 Target Increasingly Distant
SAKSOFT delivered a flat quarter (revenue ₹248.6 Cr, down 3.8% YoY) while maintaining an FY27 guidance of ₹1,200 Cr that now requires 40% H2 growth and relies on undisclosed M&A. The gap between guidance and current trajectory is the story.
₹248.6 Cr
Flat QoQ, -3.8% YoY
₹32.1 Cr
+10% QoQ, -10.7% YoY
₹497 Cr
-2% YoY
17.93%
-107 bps YoY
The core tension: guidance vs. trajectory
SAKSOFT maintained its FY27 revenue guidance of ₹1,200 Cr on the call—a nominal 19% growth from the FY26 base of ₹1,007 Cr. But H1 delivered ₹497 Cr, down 2% YoY. H2 now needs ₹703 Cr—a 40% quarter-on-quarter lift from the H1 average—to land the target. Management acknowledged this is a "tough ask" and tied it to "non-linear options" (M&A, partnerships) that have not been identified, quantified, or announced. The guidance is nominally maintained but increasingly contingent and distant from current momentum.
What's driving the shortfall
Three forces are compressing revenue and margin simultaneously:
AI-driven cannibalization: Management claims 30–50% efficiency gains, forcing team right-sizing from 50 to 30 members on product engineering. In the short term, customers reduce spend as automation replaces billable hours.
Customer in-sourcing: Multiple customers are moving work to captive centers. Called 'temporary blips' by management but acknowledged as impacting current quarter revenue visibility. Q2 revenue decline reflects this directly.
U.S. pipeline stall: The U.S. contributes ~51% of revenue. Pipeline of ~USD 25 million is not converting at expected pace; management attributed it to 'rigor' issues and lack of on-ground presence. New CEO appointment suggests urgency but execution is unproven.
50–50% AI efficiency gains; revenue cannibalization short-term.
SupportedRevenue down 3.8% YoY; customer in-sourcing admitted; team being right-sized.
100% of projects are AI; AI is a universal force.
OverstatedWhen pressed, management clarified: 'no project started because of AI only; every project uses AI in some form.'
USD 500 million target by 2030 is achievable; confident we'll get close.
ContradictedRequires 39% CAGR from flat base; last 4 quarters flat; no M&A/deal disclosed.
In-sourcing is temporary and won't derail recovery.
OverstatedCustomers actively in-sourcing work; impact to current revenue visibility real. No timeline for recovery provided.
FY27 ₹1,200 Cr guidance firm; 50% of Q3 already locked.
ContingentContingent on unspecified M&A. H2 requires 40% growth vs. H1. Current trajectory -2% YoY.
What changed on this call
New CEO & restructuring: Gurmeet Chahal (ex-public company CEO) appointed to drive U.S. scaling. Chief Growth Officer hired 3 weeks prior. New CFO and COO (Niraj Kumar) clarifying strategy. Positive signal but early-stage.
Outcome-based model shift: Currently ~10% of revenue; target to reach 29% by FY28. This is a margin-expansion play (higher pricing, stickier contracts) but adds near-term complexity and revenue recognition volatility. Management calls it a pillar of recovery.
Margin guidance deferred: Prior call implied 18%+ EBITDA margin was achievable near-term. Now deferred to 2–3 years due to outcome-based transition and sales/leadership investments. Q2 EBITDA margin 17.6%, down 66 bps QoQ from Q1 17.76%.
How the street is positioned—and what it tells us
₹134.7
as of 2026-11-11
₹107.6–₹223.0
Current +25% off low, -40% off high
₹321.75
Current -58.14% from peak
47.9
Neutral (not oversold)
The drawdown context: SAKSOFT has lost 58% from its all-time high, putting it well below both its 50- and 200-day moving averages (₹140.62 and ₹149.34, respectively). The stock is down 40% from the 52-week high of ₹223, which suggests the market began repricing well ahead of Q2. This is not an oversold washout (RSI 47.9 is neutral)—it reflects a considered repricing of execution risk.
Institutional positioning: FII ownership fell to 2.17% from 2.40% last quarter, a 23-basis-point decline. Notably, in early July—before Q2 results—bulk block deals showed significant institutional selling in the ₹209–₹211 range, well above current price. This suggests institutions were exiting ahead of the print, and the post-result price action has not recovered that selling. The market is not re-bidding the stock materially on results.
Why this matters: The combination of a 58% drawdown, FII trimming, and failed post-result recovery suggests the market is pricing in both near-term execution risk and medium-term uncertainty around guidance credibility. The stock has already undergone a reckoning; the question is whether it has gone too far or not far enough.
Risks, ranked by how much they should concern a holder
Customer concentration: top 5 = 40% of revenue; top 10 = 58%.
HighLoss of one major customer is material and limits pricing power. Churn risk in a downturn or if competitor wins a large deal.
FY27 guidance increasingly disconnected from current run-rate.
HighRequires 40% H2 growth, contingent on undefined M&A. Credibility erosion if H2 misses or M&A is not announced. Implies 'surprise' or 'reset' is likely.
AI cannibalization unresolved; team right-sizing ongoing.
HighRevenue headwind persists until outcome-based model gains traction (FY28 target). Management calls it 'short-term' but it's happening now. No clear inflection point.
U.S. pipeline conversion lagging; new CEO execution unproven.
MediumU.S. is 51% of revenue and strategic growth driver. New leadership is positive but track record on this team is zero. Execution delays risk further miss.
Margin deferred to 2–3 years; near-term compression.
MediumOutcome-based transition and leadership investments will weigh on margins. Market may not wait 2–3 years for recovery if Q3/Q4 misses or margins deteriorate further.
Macro softness; discretionary IT spend discipline ongoing.
MediumClients deferring non-strategic projects. No visibility on when this eases. Impact to pipeline conversion and deal size.
New CEO and CFO are proven public-company operators
Outcome-based model is a structural margin lever (target 29% of revenue by FY28)
AI-first transformation, if executed, creates defensibility
Stock repriced 58% from ATH; some downside already discounted
Q2 flat with margin down 66 bps QoQ; near-term momentum negative
FY27 guidance (₹1,200 Cr) contingent on undisclosed M&A; highly uncertain
H1 revenue -2% YoY; H2 needs 40% growth to hit target
AI cannibalization and customer in-sourcing are real; timeline for recovery unclear
Top 5 customers = 40% of revenue; concentration risk high
U.S. pipeline track record weak; new CEO execution unproven
Management tone shifted from bullish to cautious/defensive in Q&A
Margin guidance deferred to 2–3 years; near-term pressure
What to watch next
1 · Q3 revenue trajectory
Management claimed '50% of Q3 already locked.' If Q3 comes in below ₹240 Cr (which would maintain a flat QoQ), guidance credibility breaks further. Above ₹260 Cr would signal H2 recovery is real.
2 · M&A or partnership announcement
FY27 guidance is contingent on undefined M&A. If no deal is announced by Q3 end or Q4 start, guidance will likely be reset. Announcement would de-risk near-term narrative.
3 · Outcome-based model ramp and margin trajectory
Current outcome-based revenue ~10% of total. Ramp to 15–18% by Q3/Q4 (en route to 29% by FY28) would signal model is gaining traction. If margin stabilizes or improves QoQ, execution is credible. Further compression signals transition headwinds persist.
The number to track
From here, watch Q3 revenue guidance and revised FY27 target. If management raises or reconfirms ₹1,200 Cr with a concrete deal or path (no longer "non-linear options"), the stock has bottoming credibility. If guidance is reset downward or deferred pending M&A, the repricing likely has further to go. Outcome-based revenue % and EBITDA margin trajectory are secondary tells but matter for medium-term recovery.
SAKSOFT delivered a flat Q2 amid deliberate AI-driven revenue trade-offs and customer in-sourcing. The real question is not the quarter—it's whether FY27 guidance of ₹1,200 Cr is a pathway or a placeholder. Requiring 40% H2 growth and undefined M&A, it reads more like the latter.
Management restructuring and outcome-based model shift are credible structural positives. But they are unproven on this team and this timescale. The market has repriced sharply (−58% from ATH), and some downside has already been discounted. But credibility will hinge on whether H2 accelerates or further disappoints, and whether M&A is real or perpetually deferred.
Verdict: Hold. Wait for Q3 and M&A clarity before adding conviction either direction. The stock is no longer a bargain, but it's not yet a compulsory short. Execution in the next 6–8 weeks will tell.
Flat quarter masks AI cannibalization; FY27 guidance faces execution risk
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Guidance maintained but confidence signaled weak; H1 came in -2% YoY vs. 19–24% growth implied by FY27 target; margin compression contradicts 18%+ EBITDA goal.
Cautiously Optimistic
next 1–2 quarters
Neutral
multi-year
SAKSOFT delivered flat Q2 (revenue -3.8% YoY, PAT -10.7% YoY) amid deliberate AI-driven revenue cannibalization and customer in-sourcing. FY27 guidance of ₹1,200 Cr hinges on unspecified M&A and partnerships; H2 requires 40% growth vs. H1. Management tone is cautious, margins compressing, and execution on U.S. pipeline lagging; new CEO and outcome-based model are structural positives but unproven.
₹248.6 Cr
Revenue · −3.8% YoY₹32.1 Cr
Reported PAT · −10.7% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Second half will be better; 50% of Q3 locked in
PartialH1 revenue ₹497 Cr, down 2% YoY; Q2 flat QoQ with margin down 66 bps
50–50% AI efficiency gains; revenue cannibalization short-term
METRevenue down 3.8% YoY, customer in-sourcing admitted; team right-sizing acknowledged
100% of projects are AI; outcome-based model emerging
OVERSTATEDManagement admits no project is being done because of AI only; definition conflates using AI with starting because of AI
USD 500 million target by 2030 achievable; confident we'll get there
MISSRequires ~39% CAGR from flat base; last 4 quarters flat; no M&A/deal identified
In-sourcing is temporary blip; won't derail recovery
OVERSTATEDAdmitted customers in-sourcing work; impacts current quarter revenue visibility
Earnings quality
What changed since the last call
Revenue trajectory deteriorating
DowngradePrior call (Q1) implied 19–24% FY27 growth; Q2 came in -3.8% YoY. H1 is -2% YoY; H2 needs 40% growth to hit ₹1,200 Cr, now contingent on M&A.
Margin compression accelerating
DowngradeQ2 EBITDA margin 17.6%, down 66 bps QoQ from Q1 17.76%. H1 EBITDA margin 17.93%, down 107 bps YoY from 18.93% in H1 FY26.
Guidance hedged, execution clarity withdrawn
NeutralFY27 ₹1,200 Cr guidance nominally maintained but now described as contingent on 'non-linear options' (M&A/partnerships). Exact quantum of pipeline not shared; deferred to offline email.
Leadership restructured to drive growth
UpgradeNew CEO Gurmeet Chahal (ex-public company CEO) appointed for U.S. scaling; CFO and COO Niraj Kumar clarifying strategy. New Chief Growth Officer hired for U.S. 3 weeks prior to call.
The Q&A
Analysts pressed hard on pipeline, M&A, FY27 guidance math, and AI deflation. Management deflected or partially answered: 'don't have exact quantum,' 'will send via email,' repeated questions, semantic arguments on 100% AI projects. Tone shifted from bullish opening to cautious/defensive by Q&A, esp. on execution gaps and guidance realism.
USD 500M target clarity — Kanish Gupta, SS Family Office
PartialMammoth target. Non-linear options: M&A (inorganic) and partnerships. Confident we'll get close but last 4 quarters flat; have to be patient and wait for results.
FY27 guidance feasibility — Kanish Gupta, SS Family Office
PartialYes. Non-linear options. Tough ask but have made investments; need to be patient. 50% of Q3 already locked.
Pipeline quantum and conversion — Kanish Gupta, SS Family Office
DodgedDon't have exact quantum with me. Will send via email.
AI revenue contribution definition — Anupam Bhide, [Inaudible]
Dodged100% of projects are AI. Clarified: there is no project being done because of AI only; every project uses AI in some form. No rate cuts; efficiency gains offset by higher rates and outcome-based model.
Revenue cannibalization and team downsizing — Girish, Kaema Wealth Private Limited
Answered30–50% efficiency gains in product engineering and managed services. Short term: revenue hit as team goes from 50 to 30 members. Medium term: customer sees us as partner, spending goes back up. No clear number on deflation as of now.
U.S. pipeline maturity — Vikas S, RBC
AnsweredGood conversions in U.K. and Europe. U.S. pipeline hasn't materialized at expected pace. Rigor issue. New CEO now in place; physical presence in New York will help. Personal follow-up to convert.
Customer wallet share improvement — Rushbab, RBSA Investment Managers
DodgedDon't remember off the top of my head. Over 3 years, yes, improved significantly. [Deflected repeat question]
In-sourcing and project delays — Dhruvin Kadakia, Individual Investor
PartialFew customers in-sourced work or in process of in-sourcing. Doesn't eliminate us as partner; work goes to captive in India/elsewhere. Temporary blips. Outcome-based model and AI will help overcome.
EBITDA margin recovery timeline — Vani, Alpha Advisors
AnsweredNext 2–3 years, definitely, it can. Won't happen next 2 quarters due to sales/leadership investments and outcome-based model shift.
Growth recovery drivers — Kamal Singhania, Lotus Capital
PartialDifficult demand scenario. Aggressive sales push + partnerships. Pull strategy with new CEO. Focused on wallet share gains from existing customers.
Guidance
FY27 ₹1,200 Cr (19–24% growth from FY26 ₹1,007 Cr base)
LowMaintained but heavily hedged. H1 revenue ~₹497 Cr (down 2% YoY); H2 needs ~₹703 Cr (+40% QoQ growth). Contingent on unspecified M&A and partnerships. Management admits 'tough ask,' 'last 4 quarters flat.'
EBITDA 18%+ implied by prior guidance
LowDeferred to 2–3 years due to sales/leadership investments and outcome-based model transition. H1 EBITDA margin 17.93%, down 107 bps YoY; Q2 17.6%, down 66 bps QoQ. Near-term margin pressure.
No formal capex guidance. M&A/partnerships flagged as growth levers.
MediumCapital allocation split into 2 buckets: inorganic (M&A, needs capital) and partnership pull (no capital required for initial engagements).
Risks the call surfaced
AI cannibalization & pricing pressure
High30–50% AI efficiency gains force team right-sizing (50→30) and revenue cannibalization. Short-term hit as customers reduce spending due to improved automation. Management estimates this will resolve in medium term but no quantum.
Customer in-sourcing & project delays
MediumMultiple customers in-sourcing work to captive centers in India and elsewhere. Management acknowledges this is temporary but provides no timeline. Q2 revenue down 3.8% YoY reflects this impact.
Customer concentration
HighTop 5 customers = 40% of revenue; top 10 = 58%; top 20 = 72%. Loss of a single top-5 customer would be material. High concentration limits pricing power and creates execution risk.
U.S. execution & pipeline conversion
MediumU.S. pipeline of ~USD 25M not materializing at expected pace. Management attributes to 'rigor' and lack of on-ground presence. New CEO recently appointed to drive execution but track record unproven on this team.
Macro demand weakness & discretionary spend cuts
MediumManagement acknowledges clients continuing to exercise discretionary technology budgets discipline. Spending on strategic priorities like AI, cloud, modernization encouraged; lower-priority work deferred. No visibility on timing of normalization.
Management
Score 5/10. Transparent on challenges (cannibalization, in-sourcing, pipeline delays) but evasive on specifics (pipeline quantum, wallet share data, AI revenue definition). Made semantic argument on 100% AI projects. Track record mixed: H1 FY27 down 2% YoY vs. prior 19–24% growth guidance. U.S. pipeline slow; leadership transitions recent and unproven. New CEO and CFO appointments are positive signals but early.
1 · Q3 FY27 (Dec 2026)
New CEO Gurmeet Chahal effect on U.S. pipeline conversion; 50% of Q3 locked in per management
2 · H2 FY27 (Jan–Mar 2027)
Undisclosed M&A/partnership deals to bridge ₹1,200 Cr FY27 guidance; outcome-based model ramp
3 · FY28 onwards
AI-first transformation and outcome-based pricing to restore margin to 19–20% range
pipeline lagging; new CEO and outcome-based model are structural positives but unproven.